Jakob Ackermann1, Alexandre Barbieri Mestriner1,2, Dillon Arango3, Takahiro Ogura4, Andreas H Gomoll5. 1. Cartilage Repair Center and Center for Regenerative Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard University, Boston, MA, USA. 2. Universidade Federal de São Paulo, São Paulo, Brazil. 3. Einstein Medical Center, Philadelphia, PA, USA. 4. Sports Medicine Center, Funabashi Orthopaedic Hospital, Funabashi, Japan. 5. Hospital for Special Surgery, New York, NY, USA.
Abstract
OBJECTIVE: The purpose of this study was first to externally validate the Oswestry Risk of Knee Arthroplasty index (ORKA-1) by applying it to an autologous chondrocyte implantation (ACI) patient cohort in the United States with a broader definition of failure than only arthroplasty, and second, to determine predictive factors for the risk of ACI failure as defined by the senior author. DESIGN: A total of 171 patients that underwent ACI were included to validate the ORKA-1 as all factors needed for calculation and outcomes were recorded. For Cox regression analysis, 154 patients were included as they completed preoperative Knee Injury and Osteoarthritis Outcome Score (KOOS), Tegner, Lysholm, International Knee Documentation Committee (IKDC), and 12-item Shor Form (SF-12) scores. Patient- and lesion-associated parameters were recorded for each patient. RESULTS: At final follow-up (maximum of 10 years post-ACI), a total of 27 patients (15.8%) were considered a failure by senior author's definition. With ACI failure as endpoint, the mean survival was 7.96 years in risk group 1 and 5.4 years in risk group 5. Cox regression analysis identified preoperative KOOS Sport/Recreation as the only significant predictive factor for ACI failure (P = 0.007). CONCLUSION: The ORKA-1 is a helpful tool for surgeons to estimate an individual patient's likelihood of ACI survival. Further studies with larger patient cohorts as well as a consensus definition of failure are needed to further refine predictors of ACI failure.
OBJECTIVE: The purpose of this study was first to externally validate the Oswestry Risk of Knee Arthroplasty index (ORKA-1) by applying it to an autologous chondrocyte implantation (ACI) patient cohort in the United States with a broader definition of failure than only arthroplasty, and second, to determine predictive factors for the risk of ACI failure as defined by the senior author. DESIGN: A total of 171 patients that underwent ACI were included to validate the ORKA-1 as all factors needed for calculation and outcomes were recorded. For Cox regression analysis, 154 patients were included as they completed preoperative Knee Injury and Osteoarthritis Outcome Score (KOOS), Tegner, Lysholm, International Knee Documentation Committee (IKDC), and 12-item Shor Form (SF-12) scores. Patient- and lesion-associated parameters were recorded for each patient. RESULTS: At final follow-up (maximum of 10 years post-ACI), a total of 27 patients (15.8%) were considered a failure by senior author's definition. With ACI failure as endpoint, the mean survival was 7.96 years in risk group 1 and 5.4 years in risk group 5. Cox regression analysis identified preoperative KOOS Sport/Recreation as the only significant predictive factor for ACI failure (P = 0.007). CONCLUSION: The ORKA-1 is a helpful tool for surgeons to estimate an individual patient's likelihood of ACI survival. Further studies with larger patient cohorts as well as a consensus definition of failure are needed to further refine predictors of ACI failure.
Authors: J D Harris; R A Siston; R H Brophy; C Lattermann; J L Carey; D C Flanigan Journal: Osteoarthritis Cartilage Date: 2011-02-17 Impact factor: 6.576
Authors: Haris S Vasiliadis; Barbro Danielson; Maria Ljungberg; Brian McKeon; Anders Lindahl; Lars Peterson Journal: Am J Sports Med Date: 2010-02-25 Impact factor: 6.202
Authors: Daniel B F Saris; Johan Vanlauwe; Jan Victor; Miroslav Haspl; Michael Bohnsack; Yves Fortems; Bruno Vandekerckhove; K Frederik Almqvist; Toon Claes; Frank Handelberg; Koen Lagae; Jan van der Bauwhede; Hilde Vandenneucker; K Gie Auw Yang; Mislav Jelic; Rene Verdonk; Nancy Veulemans; Johan Bellemans; Frank P Luyten Journal: Am J Sports Med Date: 2008-02 Impact factor: 6.202
Authors: Daniel B F Saris; Johan Vanlauwe; Jan Victor; Karl Fredrik Almqvist; Rene Verdonk; Johan Bellemans; Frank P Luyten Journal: Am J Sports Med Date: 2009-10-21 Impact factor: 6.202
Authors: Nizar N Mahomed; Matthew H Liang; Earl F Cook; Lawren H Daltroy; Paul R Fortin; Anne H Fossel; Jeffrey N Katz Journal: J Rheumatol Date: 2002-06 Impact factor: 4.666
Authors: M Naomi Dugard; Jan Herman Kuiper; Jane Parker; Sally Roberts; Eric Robinson; Paul Harrison; James B Richardson Journal: Cartilage Date: 2016-07-08 Impact factor: 4.634